Skip to Content

Join the 'Cushing's Syndrome' group to help and get support from people like you.

Cushing's Syndrome News

Related terms: Cushing's Syndrome, ectopic, Cushing's Syndrome, exogenous

Signifor Approved for Cushing's Disease

Posted 17 Dec 2012 by Drugs.com

MONDAY, Dec. 17 – Signifor (pasireotide diaspartate) has been approved by the U.S. Food and Drug Administration to treat Cushing's disease in cases that cannot be treated by surgery. Cushing's occurs when the body overproduces cortisol, a hormone made by the adrenal glands. Cortisol helps regulate the body's reaction to stress and injury. People with Cushing's may be overweight, glucose ...

FDA Approves Signifor, a New Orphan Drug for Cushing’s Disease

Posted 17 Dec 2012 by Drugs.com

December 14, 2012 – The U.S. Food and Drug Administration today approved Signifor (pasireotide diaspartate) injection for the treatment of Cushing’s disease patients who cannot be helped through surgery. Cushing’s disease is caused by over-production of cortisol, a hormone made by the adrenal glands. A tumor in the pituitary gland leads to overstimulation of the adrenal gland, which results in e ...

Experimental Drug Shows Promise Against Cushing's Disease

Posted 7 Mar 2012 by Drugs.com

WEDNESDAY, March 7 – An experimental drug called pasireotide reduced levels of the "stress hormone" cortisol and improved symptoms in patients with Cushing's disease, a new study found. Cushing's disease is a rare (three to five cases per million people) hormonal disorder that causes a wide range of health problems and, if untreated, significantly increases a patient's risk of dying at a much ...

Korlym Approved for Cushing's Syndrome

Posted 20 Feb 2012 by Drugs.com

MONDAY, Feb. 20 – Korlym (mifepristone) has been approved by the U.S. Food and Drug Administration to treat endogenous Cushing's syndrome, a disabling disorder caused by overproduction of the so-called "stress hormone," cortisol. Cortisol is produced by the adrenal glands and increases blood sugar, making it particularly dangerous for people with diabetes. Korlym does not decrease production of ...

FDA Approves Korlym for Patients with Endogenous Cushing's Syndrome

Posted 17 Feb 2012 by Drugs.com

FRIDAY, February 17, 2012 – Today, Korlym (mifepristone) was approved by the U.S. Food and Drug Administration to control high blood sugar levels (hyperglycemia) in adults with endogenous Cushing’s syndrome. This drug was approved for use in patients with endogenous Cushing’s syndrome who have type 2 diabetes or glucose intolerance and are not candidates for surgery or who have not responded to p ...

Ask a Question

Further Information

Related Drug Support Groups

dexamethasone, cyproheptadine, Periactin, Decadron, mifepristone, Korlym, pasireotide, Acthrel, Adrenocot LA, view more... Dexone, Adrenocot, Dalalone, Dexamethasone Intensol, Baycadron, aminoglutethimide, Dalalone DP, Dalalone LA, Decaject, Dexpak Taperpak, Zema Pak, Signifor, Zonacort, Decaject LA, Primethasone, Medidex LA, Medidex, Dexacorten, corticorelin, Dexone LA, Dexasone LA, Dexasone, Dexacort-LA, De-Sone LA, Solurex, Dexacen-4, Solurex LA, Decadron-LA, Hexadrol, Cytadren, LoCort